Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RRM1 | P23921 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3441238 | 1.00 | MEN1 (0.50) | MEN1USP2ALDH1A1MAPTKMT2A | |
| Aspartic Acid SCHEMBL8594964 | 0.94 | MEN1 (0.45) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL1374079 | 0.88 | DPP7 (0.44) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL3229876 | 0.85 | RRM1 (0.46) | ALDH1A1DPP7RRM1GNAI3GNAO1 | |
| SCHEMBL8230008 | 0.83 | MEN1 (0.50) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL453917 | 0.83 | MEN1 (0.50) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL2806338 | 0.83 | ECE1 (0.51) | DPP7ECE1 | |
| SCHEMBL4759296 | 0.83 | DPP7 (0.44) | DPP7RRM1ECE1LTA4HGNAI3 | |
| SCHEMBL3261069 | 0.82 | DPP7 (0.50) | USP2DPP7TSHRRRM1ECE1 | |
| SCHEMBL9374114 | 0.82 | DPP7 (0.38) | DPP7RRM1ECE1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545964-A2 | CHROMATOGRAPHIC ISOLATION OF CELLS AND OTHER COMPLEX BIOLOGICAL MATERIALS | Juno Therapeutics GmbH (DE) | 2025-04-30 | — | — | EP | claimed |
| WO-2025083196-A1 | A METHOD OF MANUFACTURING A CELLULAR THERAPY PRODUCT AND RESPECTIVE KITS AND DEVICES | TQ THERAPEUTICS GMBH (DE) | 2025-04-24 | — | — | WO | claimed |
| US-20250020556-A1 | CHROMATOGRAPHIC ISOLATION OF CELLS AND OTHER COMPLEX BIOLOGICAL MATERIALS | JUNO THERAPEUTICS GMBH (DE) | 2025-01-16 | — | — | US | claimed |
| EP-2817625-B1 | CHROMATOGRAPHIC ISOLATION OF CELLS AND OTHER COMPLEX BIOLOGICAL MATERIALS | JUNO THERAPEUTICS GMBH (DE) | 2025-01-01 | — | — | EP | claimed |
| US-20240238176-A1 | ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2024-07-18 | — | — | US | claimed |
| EP-3483611-B1 | INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS | SEAGEN INC (US) | 2023-01-04 | — | — | EP | claimed |
| US-20220056083-A1 | STREPTAVIDIN MUTEINS AND METHODS OF USING THEM | IBA LIFESCIENCES GMBH (GI) | 2022-02-24 | — | — | US | claimed |
| US-11169158-B2 | Intact mass determination of protein conjugated agent compounds | SEAGEN INC. (US) | 2021-11-09 | — | — | US | claimed |
| US-20210252169-A1 | Multi-Functional Infrared-Emitting Composites | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-08-19 | — | — | US | claimed |
| US-10814017-B2 | Multifunctional infrared-emitting composites | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2020-10-27 | — | — | US | claimed |
| US-20130028951-A1 | Polymer-Liposome Nanocomposite Composition for Percutaneous Absorption, and Method for Preparing Same | AMOREPACIFIC CORPORATION (KR) | 2013-01-31 | — | — | US | claimed |
| EP-2545100-A2 | A BIODEGRADABLE POLYMERIC HYDROGEL COMPOSITION | Council of Scientific & Industrial Research (IN) | 2013-01-16 | — | — | EP | claimed |
| WO-2011111067-A2 | A BIODEGRADABLE POLYMERIC HYDROGEL COMPOSITION | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-09-15 | — | — | WO | claimed |
| EP-0749452-B1 | POLYMER-CONJUGATED MALONIC ACID DERIVATIVES AND THEIR USE AS MEDICAMENTS AND DIAGNOSTIC AGENTS | GLYCOREX AB (SE) | 2002-07-17 | — | — | EP | claimed |
| EP-0535387-B2 | Echographique particle, preparation and application | HOECHST AG (DE) | 2001-10-04 | — | — | EP | claimed |
| US-5817742-A | Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-10-06 | — | — | US | claimed |
| US-5811538-A | NORMAL PHASE COLUMN CHROMATOGRAPHY ON SUPPORT COMPRISING POLYHYDROXYETHYL ASPARTAMIDE, SILICA, HYDROPHILIC SILICA | GENTA, INCORPORATED (US) | 1998-09-22 | — | — | US | claimed |
| US-5776875-A | Use of biodegradable polymers in preventing scale build-up | NALCO CHEMICAL COMPANY (US) | 1998-07-07 | — | — | US | claimed |
| EP-0535387-B1 | Echographique particle, preparation and application | HOECHST AG (DE) | 1996-08-21 | — | — | EP | claimed |
| WO-1995018137-A1 | IMPROVED PROCESS FOR THE PURIFICATION OF OLIGOMERS | GENTA INCORPORATED (US) | 1995-07-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130028951-A1 | Polymer-Liposome Nanocomposite Composition for Percutaneous Absorption, and Method for Preparing Same | LIPA, LPXN, SLC7A1 | MEN1 510/4885USP2 860/4885ALDH1A1 4748/4885 |
| US-20240238176-A1 | ANTI-POLLUTION ECO-FRIENDLY MATERIAL AND METHOD FOR PREPARING THE SAME | CUTA, EXOSC9, EXOSC10 | MEN1 2783/4885USP2 1837/4885ALDH1A1 4401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.